Multi-Omics for Maternal Health After Preeclampsia
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Mar 25, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Multi-Omics for Maternal Health After Preeclampsia," is focused on understanding how to identify women who are at risk for heart problems after experiencing pre-eclampsia, a serious condition that can occur during pregnancy. Researchers aim to develop strategies that can help prevent these future health issues by providing the right treatments to those women after they give birth.
To participate in this study, women need to be between 18 and 50 years old and be pregnant with only one baby, enrolling between 10 to 24 weeks of their pregnancy. They must also plan to deliver at one of the study locations, which are UCSD or VUMC. If eligible, participants can expect to be part of important research that could help improve maternal health and heart health for women in the future. It’s important to know that certain conditions, like having a twin pregnancy or a serious health issue, may prevent someone from joining the study.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women 18 years of age to 50 years of age
- • 10-24 weeks gestation at time of enrollment
- • Singleton pregnancy
- • Planning to deliver at a study site (UCSD or VUMC)
- Exclusion Criteria:
- • Inability to give informed consent
- • Intrauterine fetal demise
- • Fetal genetic or structural anomaly
- • Institutionalization for psychiatric disorder, mental deficiency or incarcerated
- • Active or history of malignancy requiring major surgery or systemic chemotherapy
- • Multi-fetal gestation or a twin demise at any gestational age
- • Known maternal or fetal chromosomal anomalies
- • Patients who plan to keep their placenta after delivery
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Diego, California, United States
Patients applied
Trial Officials
Louise Laurent, MD, PhD
Principal Investigator
UCSD
Marni Jacobs, PhD
Principal Investigator
UCSD
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported